Author:
Gorji Narjes,Moeini Reihaneh,Memariani Zahra
Reference68 articles.
1. Bacopa monnieri, a neuroprotective lead in Alzheimer disease: A review on its properties, mechanisms of action, and preclinical and clinical studies;Abdul Manap;Drug Target Insights,2019
2. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial;Akhondzadeh;Journal of Neurology, Neurosurgery & Psychiatry,2003
3. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial;Akhondzadeh;Journal of Clinical Pharmacy and Therapeutics,2003
4. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: A 16-week, randomized and placebo-controlled trial;Akhondzadeh;Journal of Clinical Pharmacy and Therapeutics,2010
5. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease;Akhondzadeh;Psychopharmacology,2010